Carmentix is proud to be a sponsor and exhibitor at the 10th International Symposium on Diabetes, Hypertension, Metabolic Syndrome and Pregnancy (DIP 2019).
At the conference, we have showcased our multi-center prospective clinical trial focused on Melbourne, China and Hong Kong. It was an engaging experience with clinicians and industry leaders on the latest research in the field of women health.
Our long-time collaborator, Prof. Shaun Brennecke, also gave an oral presentation of our work on the “Novel Panel Of Midtrimester Protein Biomarkers Predict Preterm Birth”. In his talk, Prof Brennecke spoke about the bioinformatic discovery of our biomarkers and our laboratory research. Results from our clinical trials which demonstrates good sensitivity and specificity were also shared with the audience.
For more information on our latest results and partnership, please contact us at email@example.com.